
Enlivex Therapeutics Ltd. ENLV
$ 0.89
-2.01%
Annual report 2025
added 04-25-2026
Enlivex Therapeutics Ltd. DPO Ratio 2011-2026 | ENLV
Annual DPO Ratio Enlivex Therapeutics Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 193 | 106 | 18.4 | 368 | 1.03 K | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.03 K | 18.4 | 344 |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
405 | $ 0.9 | -2.33 % | $ 6.62 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
75.2 | $ 21.96 | -0.68 % | $ 3.64 B | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Amphastar Pharmaceuticals
AMPH
|
31.7 | $ 21.41 | 1.9 % | $ 1 B | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Aquestive Therapeutics
AQST
|
395 | $ 4.08 | 0.25 % | $ 436 M | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 23.26 | 1.75 % | $ 2.96 B | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.44 | -5.88 % | $ 383 M | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
182 | - | - | $ 546 M | ||
|
ContraFect Corporation
CFRX
|
1.83 K | - | -5.16 % | $ 5.39 M | ||
|
Fennec Pharmaceuticals
FENC
|
894 | $ 6.84 | 2.7 % | $ 195 M | ||
|
BioXcel Therapeutics
BTAI
|
34.2 K | $ 1.06 | -3.64 % | $ 12.9 M |